Izervay™ (avacincaptad pegol) – New drug approval
August 5, 2023 - Astellas and IVERIC bio announced the FDA approval of Izervay (avacincaptad pegol), for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD).
Download PDF
